U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ABSOLUTE
Molecular Formula C18H19N3O6S.2H2O
Molecular Weight 441.456
Optical Activity UNSPECIFIED
Defined Stereocenters 3 / 3
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of CEPHALOGLYCIN

SMILES

O.O.[H][C@]12SCC(COC(C)=O)=C(N1C(=O)[C@H]2NC(=O)[C@H](N)C3=CC=CC=C3)C(O)=O

InChI

InChIKey=KURFSUDYQUKEJZ-SBMYYUOMSA-N
InChI=1S/C18H19N3O6S.2H2O/c1-9(22)27-7-11-8-28-17-13(16(24)21(17)14(11)18(25)26)20-15(23)12(19)10-5-3-2-4-6-10;;/h2-6,12-13,17H,7-8,19H2,1H3,(H,20,23)(H,25,26);2*1H2/t12-,13-,17-;;/m1../s1

HIDE SMILES / InChI
Cephaloglycin, first oral cephalosporin, was introduced in 1965, but is no longer in common use. It is an orally absorbed derivative of cephalosporin C. Cephaloglycin binds to and inactivates penicillin-binding proteins (PBPs) located on the inner membrane of the bacterial cell wall. PBPs are enzymes involved in the terminal stages of assembling the bacterial cell wall and in reshaping the cell wall during growth and division. Inactivation of PBPs interferes with the cross-linkage of peptidoglycan chains necessary for bacterial cell wall strength and rigidity. This results in the weakening of the bacterial cell wall and causes cell lysis.

Approval Year

TargetsConditions

Conditions

ConditionModalityTargetsHighest PhaseProduct
Curative
KAFOCIN

Approved Use

For treatment of severe infections caused by susceptible bacteria.

Launch Date

1970
Cmax

Cmax

ValueDoseCo-administeredAnalytePopulation
0.8 μg/mL
0.5 g single, oral
dose: 0.5 g
route of administration: Oral
experiment type: SINGLE
co-administered:
CEPHALOGLYCIN plasma
Homo sapiens
population: HEALTHY
age: ADULT
sex: FEMALE / MALE
food status: FED
AUC

AUC

ValueDoseCo-administeredAnalytePopulation
3 μg × h/mL
0.5 g single, oral
dose: 0.5 g
route of administration: Oral
experiment type: SINGLE
co-administered:
CEPHALOGLYCIN plasma
Homo sapiens
population: HEALTHY
age: ADULT
sex: FEMALE / MALE
food status: FED
T1/2

T1/2

ValueDoseCo-administeredAnalytePopulation
1 h
0.5 g single, oral
dose: 0.5 g
route of administration: Oral
experiment type: SINGLE
co-administered:
CEPHALOGLYCIN plasma
Homo sapiens
population: HEALTHY
age: ADULT
sex: FEMALE / MALE
food status: FED
Funbound

Funbound

ValueDoseCo-administeredAnalytePopulation
75%
0.5 g single, oral
dose: 0.5 g
route of administration: Oral
experiment type: SINGLE
co-administered:
CEPHALOGLYCIN plasma
Homo sapiens
population: HEALTHY
age: ADULT
sex: FEMALE / MALE
food status: FED
Overview

Overview

CYP3A4CYP2C9CYP2D6hERG

OverviewOther

Other InhibitorOther SubstrateOther Inducer

Drug as perpetrator​

Drug as perpetrator​

PubMed

PubMed

TitleDatePubMed
Oxidative and mitochondrial toxic effects of cephalosporin antibiotics in the kidney. A comparative study of cephaloridine and cephaloglycin.
1989 Mar 1
beta-Lactam drug allergens: fine structural recognition patterns of cephalosporin-reactive IgE antibodies.
1996 Jul-Aug
Plasma glutathione peroxidase and its relationship to renal proximal tubule function.
1998 Nov
Determination of cephalosporins in solid binary mixtures by polarized IR- and Raman spectroscopy.
2008 Sep 10
Protein engineering of penicillin acylase.
2010 Jul
Patents

Patents

Sample Use Guides

Each subject received a single oral dose of each of the following: 250, 500, and 1,000 mg of cephaloglycin after an overnight fast
Route of Administration: Oral
In Vitro Use Guide
Curator's Comment: All strains of group A streptococci (Streptococcus pyogenes) and Diplococcus pneumoniae were inhibited by 0.4 ug of cephaloglycin per ml. https://www.ncbi.nlm.nih.gov/pubmed/4385749
M. hyorhinis strains were susceptible to cephaloglycin (MIC = 4.1 ug/ml)
Name Type Language
CEPHALOGLYCIN
ORANGE BOOK   USAN  
USAN  
Official Name English
39435
Code English
5-THIA-1-AZABICYCLO(4.2.0)OCT-2-ENE-CARBOXYLIC ACID, 3-((ACETYLOXY)METHYL)-7-((AMINOPHENYLACETYL)AMINO)-8-OXO-, (6R-(6.ALPHA.,7.BETA.(R*))), DIHYDRATE
Common Name English
KEFOCIN
Brand Name English
7-(D-.ALPHA.-AMINOPHENYLACETAMIDO)-CEPHALOSPORANIC ACID DIHYDRATE
Common Name English
CEPHALOGLYCIN [ORANGE BOOK]
Common Name English
CEFALOGLYCIN DIHYDRATE
Common Name English
CEPHALOGLYCIN [USAN]
Common Name English
(6R,7R)-7-[(R)-2-Amino-2-phenylacetamido)-3-(hydroxymethyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid acetate (ester) dihydrate
Common Name English
KAFOCIN
Brand Name English
CEPHALOGLYCIN DIHYDRATE [MI]
Common Name English
Classification Tree Code System Code
NCI_THESAURUS C357
Created by admin on Fri Dec 15 15:02:17 GMT 2023 , Edited by admin on Fri Dec 15 15:02:17 GMT 2023
Code System Code Type Description
NCI_THESAURUS
C65307
Created by admin on Fri Dec 15 15:02:17 GMT 2023 , Edited by admin on Fri Dec 15 15:02:17 GMT 2023
PRIMARY
CAS
22202-75-1
Created by admin on Fri Dec 15 15:02:17 GMT 2023 , Edited by admin on Fri Dec 15 15:02:17 GMT 2023
PRIMARY
PUBCHEM
166592
Created by admin on Fri Dec 15 15:02:17 GMT 2023 , Edited by admin on Fri Dec 15 15:02:17 GMT 2023
PRIMARY
EPA CompTox
DTXSID20176751
Created by admin on Fri Dec 15 15:02:17 GMT 2023 , Edited by admin on Fri Dec 15 15:02:17 GMT 2023
PRIMARY
FDA UNII
NE7R11LA95
Created by admin on Fri Dec 15 15:02:17 GMT 2023 , Edited by admin on Fri Dec 15 15:02:17 GMT 2023
PRIMARY
ChEMBL
CHEMBL1200971
Created by admin on Fri Dec 15 15:02:17 GMT 2023 , Edited by admin on Fri Dec 15 15:02:17 GMT 2023
PRIMARY
WIKIPEDIA
Cephaloglycin
Created by admin on Fri Dec 15 15:02:17 GMT 2023 , Edited by admin on Fri Dec 15 15:02:17 GMT 2023
PRIMARY
DRUG BANK
DBSALT001839
Created by admin on Fri Dec 15 15:02:17 GMT 2023 , Edited by admin on Fri Dec 15 15:02:17 GMT 2023
PRIMARY
MERCK INDEX
m1064
Created by admin on Fri Dec 15 15:02:17 GMT 2023 , Edited by admin on Fri Dec 15 15:02:17 GMT 2023
PRIMARY Merck Index
MESH
D002507
Created by admin on Fri Dec 15 15:02:17 GMT 2023 , Edited by admin on Fri Dec 15 15:02:17 GMT 2023
PRIMARY